24Serious

Gustavo Barros Schelotto

Gustavo Barros Schelotto

Ask VT AI

View News Summary

Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
U.S. and China finalize TikTok transfer deal, part of broader agreement
China's industrial profits surge in September, led by high-tech and equipment manufacturing, despite ongoing economic headwinds.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
U.S. and China finalize TikTok transfer deal, part of broader agreement
China's industrial profits surge in September, led by high-tech and equipment manufacturing, despite ongoing economic headwinds.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Gustavo Barros Schelotto